A trial evaluating the systemic and ecological impact of zinc-biofortified maize consumption on cellular zinc status, inflammatory biomarkers, and gut microbiota composition in a cohort of Guatemalan mothers and children.
This is a pilot study conducted among a subset of participants in a larger food aid intervention program using biofortified maize (N=499). This analysis focuses on a highly compliant cohort of 30 households (N=60 individuals) providing high-fidelity multi-omic data.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
60
Daily consumption of zinc-biofortified maize (F3) for up to 10 months.
Daily consumption of conventional maize for the duration of the study.
Institute of Nutrition of Central America and Panama (INCAP)
Guatemala City, Departamento de Guatemala, Guatemala
Cellular Zinc Status (LA:DGLA Ratio)
Physiological zinc status measured via red blood cell (RBC) long-chain fatty acid analysis, specifically the linoleic acid to dihomo-gamma-linolenic acid (LA:DGLA) ratio
Time frame: Up to 10 months (Sept 2022 (baseline) thru August 2023 (final assessment))
Iron Status
Hemoglobin and Serum Ferritin levels (adjusted and unadjusted for inflammation)
Time frame: Up to 10 months (September 2022 (baseline) thru August 2023 (final assessment))
Systemic Inflammation
Measured via high-sensitivity C-reactive protein (hsCRP)
Time frame: Up to 10 months (September 2022 (baseline) thru August 2023 (final assessment))
Gut Microbiota
Characterization of fecal microbiota using 16S rRNA sequencing
Time frame: Up to 10 months (September 2022 (baseline) thru August 2023 (final assessment))
Fecal Calprotectin
Measurement of fecal calprotectin as a marker of intestinal inflammation.
Time frame: Up to 10 months (September 2022 (baseline) thru August 2023 (final assessment))
Fecal Fatty Acid Profiles
Quantification of short-chain fatty acids (SCFA) and branched-chain fatty acids (BCFA) in stool samples.
Time frame: Up to 10 months (September 2022 (baseline) thru August 2023 (final assessment))
Nutritional Biomarkers
Serum Vitamin B12 and Serum Albumin levels.
Time frame: Up to 10 months (September 2022 (baseline) thru August 2023 (final assessment))
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.